UNLABELLED: The aim of this study was to determine the prognostic value of a coronary artery calcium score (CACS) of 0 in patients with stable chest symptoms and to compare it as a first-line test with bicycle exercise testing (X-ECG). Altogether, 315 consecutive patients over 44 years of age, with stable chest symptoms and no previous diagnosis of coronary artery disease (CAD) visited the outpatient clinic of our community hospital and underwent both CACS and X-ECG. The mean age was 60.54 years (SD 9.7; range 45-88 years). Of these patients, 141 had no detectable coronary calcium (44.8%) We excluded patients who did not sign informed consent (n = 4). Three patients were lost to follow-up. The follow-up group therefore consisted of 134 patients. The mean follow-up period was 44.6 months (25th-75th percentile: 35.5-54.3 months), during which no major adverse cardiac events (MACE) occurred. The negative predictive value (NPV) was 100%. X-ECG was negative in only 89 patients, equivocal in 39 patients and false-positive in 6 patients requiring additional stress myocardial imaging in 45 patients. NPV as a first-line test was therefore 66.4%. IN CONCLUSION: patients over 44 years with stable chest symptoms and no detectable coronary calcium have an excellent prognosis. CACS performs better compared with X-ECG as an initial test in patients with stable chest symptoms.
UNLABELLED: The aim of this study was to determine the prognostic value of a coronary artery calcium score (CACS) of 0 in patients with stable chest symptoms and to compare it as a first-line test with bicycle exercise testing (X-ECG). Altogether, 315 consecutive patients over 44 years of age, with stable chest symptoms and no previous diagnosis of coronary artery disease (CAD) visited the outpatient clinic of our community hospital and underwent both CACS and X-ECG. The mean age was 60.54 years (SD 9.7; range 45-88 years). Of these patients, 141 had no detectable coronary calcium (44.8%) We excluded patients who did not sign informed consent (n = 4). Three patients were lost to follow-up. The follow-up group therefore consisted of 134 patients. The mean follow-up period was 44.6 months (25th-75th percentile: 35.5-54.3 months), during which no major adverse cardiac events (MACE) occurred. The negative predictive value (NPV) was 100%. X-ECG was negative in only 89 patients, equivocal in 39 patients and false-positive in 6 patients requiring additional stress myocardial imaging in 45 patients. NPV as a first-line test was therefore 66.4%. IN CONCLUSION:patients over 44 years with stable chest symptoms and no detectable coronary calcium have an excellent prognosis. CACS performs better compared with X-ECG as an initial test in patients with stable chest symptoms.
Authors: Jacob M van Werkhoven; Stephanie M de Boer; Joanne D Schuijf; Filippo Cademartiri; Erica Maffei; J Wouter Jukema; Mark J Boogers; Lucia J Kroft; Albert de Roos; Jeroen J Bax Journal: Am J Cardiol Date: 2010-11-04 Impact factor: 2.778
Authors: Ilan Gottlieb; Julie M Miller; Armin Arbab-Zadeh; Marc Dewey; Melvin E Clouse; Leonardo Sara; Hiroyuki Niinuma; David E Bush; Narinder Paul; Andrea L Vavere; John Texter; Jeffery Brinker; João A C Lima; Carlos E Rochitte Journal: J Am Coll Cardiol Date: 2010-02-16 Impact factor: 24.094
Authors: K F Fox; M R Cowie; D A Wood; A J Coats; J S Gibbs; S R Underwood; R M Turner; P A Poole-Wilson; S W Davies; G C Sutton Journal: Eur Heart J Date: 2001-02 Impact factor: 29.983
Authors: Manesh R Patel; Eric D Peterson; David Dai; J Matthew Brennan; Rita F Redberg; H Vernon Anderson; Ralph G Brindis; Pamela S Douglas Journal: N Engl J Med Date: 2010-03-11 Impact factor: 91.245
Authors: K Nieman; T Galema; A Weustink; L Neefjes; A Moelker; P Musters; R de Visser; N Mollet; H Boersma; P J de Feijter Journal: Heart Date: 2009-07-20 Impact factor: 5.994
Authors: Kamran Akram; Robert E O'Donnell; Spencer King; H Robert Superko; Arthur Agatston; Szilard Voros Journal: Atherosclerosis Date: 2008-07-19 Impact factor: 5.162
Authors: J Schaap; R M Kauling; S M Boekholdt; M C Post; J A Van der Heyden; T L de Kroon; B J W M Rensing; J F Verzijlbergen Journal: J Nucl Cardiol Date: 2012-02 Impact factor: 5.952
Authors: Jeroen Schaap; Robert M Kauling; S Matthijs Boekholdt; Martijn C Post; Jan A Van der Heyden; Thom L de Kroon; H Wouter van Es; Benno J W M Rensing; J Fred Verzijlbergen Journal: Int J Cardiovasc Imaging Date: 2012-08-18 Impact factor: 2.357
Authors: Moniek Y Koopman; Robert T A Willemsen; Pim van der Harst; Rykel van Bruggen; Jan Willem C Gratama; Richard Braam; Peter M A van Ooijen; Carine J M Doggen; Geert-Jan Dinant; Bas Kietselaer; Rozemarijn Vliegenthart Journal: Rofo Date: 2022-01-26
Authors: K H Yiu; F R de Graaf; J E van Velzen; N A Marsan; C J Roos; M K de Bie; H F Tse; E E van der Wall; M J Schalij; J J Bax; J D Schuijf; J W Jukema Journal: Neth Heart J Date: 2013-07 Impact factor: 2.380